(Reuters) -The UK’s benchmark FTSE 100 was little changed on Tuesday, as gains in pharma giant AstraZeneca were offset by declines in the automobile and parts sector, while investors indulged in some profit-taking ahead of a crucial domestic inflation reading.
The blue-chip FTSE 100 lost 0.1%, while the mid-cap FTSE 250 was off 0.4%.
The automobile and parts sector declined 4.0%, the biggest sectoral fall, pulled down by a 6.1% loss in Dowlas Group, after the GKN automotive owner warned of lower revenue in the year.
Nearly half of the sectors closed lower while the pharma and biotech sector offset some losses with a 1.1% gain, pulled up by AstraZeneca, which advanced 2.2% after the drugmaker said it aimed to grow its revenue by 75% to $80 billion by 2030.
“The FTSE has run very far, very fast and there’s a bit of profit-taking. Defensive sectors are winning out and I think…
